Literature DB >> 17898544

The influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cells.

Amandine Pradier1, Camille Ettelaie.   

Abstract

BACKGROUND: The exposure of tissue factor (TF) at the site of injury or trauma is a rapid process that leads to the initiation of blood coagulation as well as homeostatic processes giving rise to vascular repair. AIMS AND METHODS: By exposing human endothelial cells to combinations of exogenous TF and factor VIIa (FVIIa) in serum-free medium, the influence of TF concentrations on cellular proliferation and apoptosis was investigated.
RESULTS: Lower concentrations of TF resulted in increased cellular proliferation as well as upregulation of cyclin D1, downregulation of p21 and p27 and induction of tube formation in vitro. Conversely, incubation with higher concentrations of TF resulted in the activation of caspase-3, expression of p53 and Bax, translocation of p53 into the nucleus and induction of DNA fragmentation. Incubation of the cells with TF/FVIIa led to a lower proliferation rate with additional upregulation in p27.
CONCLUSIONS: TF seems to have a bifunctional role in determining the fate of endothelial cells, depending on the concentration and the interactions of this protein. The release of TF in the locality of the injured tissue makes this protein an ideal factor for ascertaining the level of injury and determining the fate of the cells. Copyright (c) 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898544     DOI: 10.1159/000109074

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  8 in total

Review 1.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

2.  Differential induction of cellular proliferation, hypertrophy and apoptosis in H9c2 cardiomyocytes by exogenous tissue factor.

Authors:  G Alkistis Frentzou; Mary E W Collier; Anne-Marie L Seymour; Camille Ettelaie
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

3.  Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor.

Authors:  Mary E W Collier; Camille Ettelaie
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

Review 4.  Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer.

Authors:  Céline Bouvy; Damien Gheldof; Christian Chatelain; François Mullier; Jean-Michel Dogné
Journal:  J Extracell Vesicles       Date:  2014-07-11

5.  Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day.

Authors:  Chris Gardiner; Paul Harrison; Mattias Belting; Anita Böing; Elena Campello; Bob S Carter; Mary E Collier; Frank Coumans; Camille Ettelaie; Nick van Es; Fred H Hochberg; Nigel Mackman; Robert C Rennert; Johannes Thaler; Janusz Rak; Rienk Nieuwland
Journal:  J Extracell Vesicles       Date:  2015-03-13

6.  Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities.

Authors:  Mohammad A Mohammad; John Greenman; Anthony Maraveyas; Camille Ettelaie
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

7.  Procoagulant tumor microvesicles attach to endothelial cells on biochips under microfluidic flow.

Authors:  Abdulrahman Algarni; John Greenman; Leigh A Madden
Journal:  Biomicrofluidics       Date:  2019-12-06       Impact factor: 2.800

8.  Accumulation of tissue factor in endothelial cells promotes cellular apoptosis through over-activation of Src1 and involves β1-integrin signalling.

Authors:  Ali M Ethaeb; Mohammad A Mohammad; Yahya Madkhali; Sophie Featherby; Anthony Maraveyas; John Greenman; Camille Ettelaie
Journal:  Apoptosis       Date:  2020-02       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.